Biomedical Engineering Reference
In-Depth Information
70. Sakurai Y, Motohashi H, Ogasawara K, Terada T, Masuda S, Katsura T, Mori N,
Matsuura M, Doi T, Fukatsu A, Inui K. 2005. Pharmacokinetic significance of renal
OAT3 (SLC22A8) for anionic drug elimination in patients with mesangial proliferative
glomerulonephritis. Pharm Res 22(12):2016-2022.
71. Miller DS. 2004. Confocal imaging of xenobiotic transport across the choroid plexus. Adv
Drug Deliv Rev 56(12):1811-1824.
72. Kusuhara H, Sugiyama Y. 2004. Efflux transport systems for organic anions and cations at
the blood-CSF barrier. Drug Transfer Choroid Plexus Multiplicity Substr Specif Transport
56(12):1741.
73. Syme MR, Paxton JW, Keelan JA. 2004. Drug transfer and metabolism by the human
placenta. Clin Pharmacokinet 43(8):487-514.
74. Zhou F, Illsley NP, You G. 2006. Functional characterization of a human organic anion
transporter hOAT4 in placental BeWo cells. Eur J Pharm Sci 27(5):518-523.
75. Monte JC, Nagle MA, Eraly SA, Nigam SK. 2004. Identification of a novel murine organic
anion transporter family member, OAT6, expressed in olfactory mucosa. Biochem Biophys
Res Commun 323(2):429-436.
76. Schnabolk GW, Youngblood GL, Sweet DH. 2006. Transport of estrone sulfate by the novel
organic anion transporter Oat6 (Slc22a20). Am J Physiol Renal Physiol 291(2):314-321.
77. Graessler J, Graessler A, Unger S, Kopprasch S, Tausche AK, Kuhlisch E, Schroeder HE.
2006. Association of the human urate transporter 1 with reduced renal uric acid excretion
and hyperuricemia in a German Caucasian population. Arthritis Rheum 54(1):292-300.
78. Iwai N, Mino Y, Hosoyamada M, Tago N, Kokubo Y, Endou H. 2004. A high prevalence of
renal hypouricemia caused by inactive SLC22A12 in Japanese. Kidney Int 66(3):935-944.
79. Hediger MA, Johnson RJ, Miyazaki H, Endou H. 2005. Molecular physiology of urate
transport. Physiology (Bethesda) 20:125-133.
80. Tahara H, Kusuhara H, Maeda K, Koepsell H, Fuse E, Sugiyama Y. 2006. Inhibition of oat3-
mediated renal uptake as a mechanism for drug-drug interaction between fexofenadine and
probenecid. Drug Metab Dispos 34(5):743-747.
81. Sweet DH. 2005. Organic anion transporter (Slc22a) family members as mediators of
toxicity. Toxicol Appl Pharmacol 204(3):198.
82. Eraly SA, Monte JC, Nigam SK. 2004. Novel slc22 transporter homologs in fly, worm,
and human clarify the phylogeny of organic anion and cation transporters. Physiol Genom
18(1):12-24.
83. Eraly SA, Roland C, Bhatnagar V, Nigam SK. 2003. Novel aspects of renal organic anion
transporters. Curr Opin Nephrol Hypertension 12(5):551-558.
84. Young blood GL, Sweet DH. 2004. Identification and functional assessment of the novel
murine organic anion transporter Oat 5 (Slc 22a 19) expressed in kidney. Am J Physiol
Renal Physiol 287(2):236-244.
85. Mori K, Ogawa Y, Ebihara K, Aoki T, Tamara N, Sugawaa A, Kuwahara T, Ozaki S,
Mukoyama M, Tashiro K. 1997. Kidney-specific expression of a novel mouse organic
cation transporter-like protein. FEBS Lett 417(3):371.
Search WWH ::
Custom Search